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OBJECTIVE: To evaluate the influence of physical training with or without noninvasive ventilation at 2 levels of pressure in the
airways (BiPAP®) in patients with chronic obstructive pulmonary disease.
METHODS: Eighteen patients with FEV1 = 34 ± 8% of predicted values, mean age of 68 ± 9 years were randomly distributed
into 2 groups, one group performing physical training on a treadmill and the other group performing physical training associated
with BiPAP® (physical training+B), for 30 minutes, 3 times a week for 12 weeks. The training velocity was based on a test of
cardiopulmonary force performed pre- and postintervention, which registered the values for heart rate, systolic blood pressure,
diastolic blood pressure, peripheral oxygen saturation, blood lactate, sensation of dyspnea, respiratory muscle strength, and analysis
of gases expired such as oxygen consumption and the production of carbon dioxide.
RESULTS: For both groups, there was a significant improvement in dyspnea and peripheral oxygen saturation at identical levels
of physical exercise, in distance walked during the physical training, and in respiratory muscle strength (P < 0.05). Only the
physical training+B group had a significant improvement in heart rate, systolic blood pressure, and oxygen consumption after
training (P < 0.05). Significant reductions of blood lactate were observed at identical levels of exercise in physical training+B
when compared to isolated physical training (from 1.3 ± 0.7 mMol/L versus 2.5 ± 0.9 mMol/L, (P < 0.05), respectively).
CONCLUSION: Physical training associated with BiPAP® enhanced the oxidative muscular capacity and could be an adjunctive
recourse for physical rehabilitation in patients with chronic obstructive pulmonary disease.
KEYWORDS: Chronic obstructive pulmonary disease (COPD). Physical training. BiPAP®. Noninvasive ventilation.
Cardiopulmonary test.
INTRODUCTION
Patients with chronic obstructive pulmonary disease
(COPD) present a greater limitation in physical exercise
due to dyspnea.1–3 Increased airway resistance, insufficient
ventilation, hyperinsuflation, respiratory muscle mechani-
cal disability, and gas exchange abnormalities associated
with the symptoms of dyspnea contribute to the ventilatory
limitation during effort in these patients.1,4,5
Physical training, in general, has the objective of im-
proving the efficiency of the capacity of the uptake sys-
tem, transport, and metabolism of oxygen6 and is essential
in the treatment of patients with COPD, as its objective is
to improve tolerance for physical exercise, respiratory mus-
cle effort, and endurance as well as reduce the symptoms
of dyspnea.7–11
According to Bourjeily & Rochester,12 physical train-
ing should have a duration of 6 to 12 weeks at a frequency
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of 3 times per week. Some studies have demonstrated that
6 weeks of physical training can provide an increased func-
tional capacity for these patients,7,9,13 although the short pe-
riod of physical training may be a limiting factor12 for se-
rious cases. In patients with greater functional limitations,
the use of noninvasive ventilation (NIV) at 2 pressure lev-
els (BiPAP®) used as an adjunct to physical training has
been studied in patients with COPD. It is believed that posi-
tive pressure is available during the auxiliary inspiratory
phase of ventilation in the patient and reduces the work of
the respiratory musculature, diminishing the intrinsic posi-
tive end expiratory pressure (PEEPi) through the constant
application of expiratory support.14–17
Costes et al18 conducted a physical training program us-
ing an ergometric bicycle for 8 weeks associated with NIV
(BiPAP®) and observed a significant increase in the oxy-
gen consumption (VO2) compared to physical training
alone. However, Bianchi et al19 did not find additional ef-
fects from proportional assisted ventilation support when
associated with a physical training program for patients
with COPD.
We hypothesized that physical training on a treadmill
with BiPAP compared to physical training without BiPAP




Eighteen individuals of both sexes were referred to the
Respiratory Physical Therapy Service at the Federal Univer-
sity of São Carlos (UFSCar) between February and Decem-
ber 2004 by medical prescription with a clinical and spiro-
metric diagnosis of COPD. The patients underwent a gen-
eral evaluation and specific respiratory system testing of pul-
monary function (spirometry) using a portable spirometer
(Vitalograph, Hand Held 2021) in an acclimatized room
(22ºC to 24ºC). The technical procedures, criteria of accept-
ability, and reproducibility were performed according to
specifications adopted by the American Thoracic Society.20
The reference values of Knudson et al21 were used.
The criteria for inclusion in the study were the follow-
ing: Patients should present a forced expiratory volume on
first second (FEV1) < 60% and FEV1/FVC < 70% of the
predicted20 as well as should be clinically stable for a mini-
mum period of 6 months and present no associated cardio-
vascular diseases, orthopedic diseases, reactive hyperten-
sion relative to effort, nor neuromuscular disorders that
would impede the performance of the experimental proce-
dures in this study.
After having the objectives and procedures that would
be performed explained to them, patients signed a Term
of Consent for participation in the proposed program in ac-
cordance with the recommendations of Resolution 196/96
of the National Health Council of Brazil. This study was
approved by the Committee for Ethical Research on Hu-
man Beings of the institution.
Experimental Design
Before and after the treatment, patients underwent the
following evaluations:
Respiratory Muscle Strength. Respiratory muscle
strength was obtained using an analogic manovacumeter
with a cm H2O scale, (Ger-ar; SP, Brasil). Maximal inspira-
tory pressure (PImax) and maximal expiratory pressure
(PEmax) were measured according to the method described
by Black and Hyatt,22 in which the individual uses a nose
clip while remaining in an orthostatic position. PImax was
measured from residual volume after maximum expiration,
and PEmax was measured close to total pulmonary capac-
ity, after maximum inspiration. The individuals were in-
structed to maintain pressure for more than 1 second, and
each maneuver was performed a minimum of 3 times, with
the highest value used for the analysis.23
Cardiopulmonary Physical Testing (CPT). Cardiop-
ulmonary physical testing (CPT) was carried out on an
Inbramed Milenium treadmill model ATL (RS, Brazil) us-
ing an increasing speed protocol, beginning at 2 km/h, for
2 minutes, with increments of 0.5 km/h at every 2 min-
utes. Continuous monitoring was done throughout the test
using a Nonin 8400A pulse oximeter (Plymouth, USA) for
peripheral oxygen saturation (SpO2), heart rate (HR) using
a frequencymeter (Polar Precision Performance, Kemple,
Finland), and an electrocardiogram monitor using an Ecafix
TC 500 (SP, Brazil). Also were recorded were the SpO2,
HR, and sensation of dyspnea using a Borg CR10 modi-
fied scale.24 The systolic blood pressure (SBP) and diastolic
blood pressure (DBP) were measured on the left upper arm
using an sphygmomanometer by indirect method. Blood
samples were collected from the earlobe for blood lactate
analysis. Blood lactate was measured at rest and every 2
minutes during the test. The interruption criteria for CPT
were an intense sensation of dyspnea, arrhythmia, increase
in HR above the maximum predicted for the age of the in-
dividual, or drops in SpO2 < 80%.
Blood Lactate Dosage after aseptic cleaning of the re-
gion with alcohol; a puncture in the earlobe was made with
a disposable lancet. The first drop of blood was discarded
to avoid contamination by lactate eliminated through sweat.
Each arterial blood sample was collected in a capillary tube
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previously treated with 25 ml of heparin. The blood was
deposited into 2 mL Eppendorf tubes containing 50 ml of
1% sodium fluoride as a glycolysis preservative. The blood
was stored at –10ºC for later analysis. Blood lactate con-
centration was performed using a portable electrochemical
lactometer (YSI model 1500 Sport lactometer, Yellow
Springs Inc. USA) using the electro-enzymatic method.
Analysis of Expired Gas. Analysis of expired gas was
performed using a metabolic system (MedGraphis Model
VO2000, St Paul MN, USA), operated by microcomputer
(Pentium II) using Aerograph software for capture and stor-
age of signals. The VO2000 measured microsamples of expired
gas at the rate of 20 in 20 seconds, and the metabolic data
generated were plotted in graphs and tables. The variables
analyzed were VO2 (L/min) and VCO2 (L/min), expressed
at standard temperature and pressure dry (STPD).
Treatments. The patients were divided randomly into
2 groups, one undergoing physical training on a treadmill
(PT) and the second undergoing PT associated with the use
of bi-level NIV (PT+B), using a BiPAP® (S-Respironics
Inc., Pennsylvania-USA). Through a nasal mask, inspira-
tory pressure levels (IPAP) between 10 and 15 cm H2O and
expiratory pressure levels (EPAP) between 4 and 6 cm H2O
were applied to the airways, adjusted in accordance with
the tolerance and comfort reported by each patient. The in-
spiratory level was set at 5 cm H2O and was increased
gradually by 2 cm H2O every minute to a maximum of 15
cm H2O. Expiratory pressure was set at 3 cm H2O and was
increased gradually by 1 cm H2O every minute to a maxi-
mum of 6 cm H2O. The gradual increase in both the in-
spiratory and expiratory pressures was aimed at increasing
comfort and compliance in volunteers. These values were
set in an arbitrary manner and designed to provide what
would be considered by most patients as mild expiratory
pressure and moderate inspiratory pressure support.
For both groups, the protocol was administered in 30-
minute sessions, 3 days a week on alternate days, for 12
weeks. The intensity of the applied training corresponded
to 70% of the maximum speed reached by each patient at
the pretreatment CPT.
Statistical Analysis. Due to the non-normal distribution
of the data, the Wilcoxon and Mann Whitney nonparametric
tests were used for intragroup and intergroup comparisons,
respectively, with the level of significance set at level of sig-
nificance of P d” 0.05.
RESULTS
The anthropometric and demographic characteristics of
the study population are presented in Table 1. All patients
had moderate to severe COPD, as evidenced by reduced
forced expiratory volume in 1 second (FEV1), and force vi-
tal capacity (FVC) in both groups. No significant differ-
ences were found between the groups, characterizing the
homogeneity of the sample.
Regarding cardiopulmonary variables (HR, SBP, DBP),
SpO2, sensation of dyspnea and blood lactate pre-and
posttreatment, for both the PT and the PT+B group, there
was a significant increase of SpO2 (85% ± 8% to 89% ± 8%
and 81% ± 4% to 87% ± 4%; respectively) and decrease of
dyspnea (4.2 ± 2.1 to 1.4 ± 1.4 and 4.0 ± 1.5 to 1.5 ± 1.8,
respectively) (Table 2). However, the HR (110.7 ± 15.2 to
103.7 ± 11.5 bpm), SBP (164.4 ± 22.9 to 140.0 ± 21.9 mm
Hg), and blood lactate (1.7 ± 0.7 to 1.3 ± 0.7mMol/L) were
Table 1 - Anthropometric and pulmonary function tests of the study population in the physical training (PT) alone or
associated with BiPAP (BT+B) groups
VARIABLES PT PT+B Mann-Whitney
Age (years) 67.6 ± 8.5 66.8 ± 10.6 Not significant
Weight (kg) 72.2 ± 16.1 71.4 ± 10.7 Not significant
Height (m) 1.6 ± 0.1 1.6 ± 0.06 Not significant
Body Mass Index (kg/m2) 27.3 ± 6.0 26.4 ± 4.4 Not significant
Vital Capacity (L) 2.0 ± 0.6 2.0 ± 0.7 Not significant
Vital Capacity (%) 58 ± 11 60 ± 21 Not significant
Forced Vital Capacity (L) 1.8 ± 0.4 1.9 ± 0.7 Not significant
Forced Vital Capacity (%) 55 ± 11 63 ± 18 Not significant
Forced expiratory volume in 1 second (L) 0.8 ± 0.2 0.7 ± 0.3 Not significant
Forced expiratory volume in 1 second (%) 34 ± 8 33 ± 10 Not significant
Forced expiratory volume in 1 second/ Forced Vital Capacity (%) 48 ± 9 41 ± 17 Not significant
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Table 2 - Results obtained at identical exercise levels during cardiopulmonary physical testing in the 2 groups
PT PT+B
PRE  POST  PRE POST
Speed (km/h) 2.6 ± 0.9 2.6 ± 0.9 2.8 ± 0.6 2.8 ± 0.6
Peripheral Oxygen Saturation (%) 85 ± 8 89 ± 8* 81 ± 4 87 ± 4*
Heart Rate (bpm) 119.4 ± 8.9 114.1 ± 11.4 110.7 ± 15.2 103.7 ± 11.5*
Systolic Blood Pressure (mm Hg) 151.6 ± 22.9 138.8 ± 9.2 164.4 ± 22.9 140.0 ± 21.9*
Diastolic Blood Pressure (mm Hg) 88.8 ± 16.9 84.4 ± 14.2 86.6 ± 7.0 84.4 ± 10.1
Dyspnea (Borg) 4.2 ± 2.1 1.4 ± 1.4* 4.0 ± 1.5 1.5 ± 1.8*
Blood Lactate (mMol/L) 2.0 ± 1.0 2.5 ± 0.9 1.7 ± 0.7 1.3 ± 0.7*†
*Significantly different from pre-training. P d” 0.05. †Significantly different between groups. P d” 0.05.
Table 3 - Results obtained at peak exercise during cardiopulmonary physical testing in the 2 groups
PT PT+B
PRE  POST  PRE POST
Speed (km/h) 2.6 ± 0.9 4.1 ± 1* 2.8 ± 0.6 4.1 ± 1*
Peripheral Oxygen Saturation peak (%) 85 ± 8 85 ± 8 81 ± 4 82 ± 5
Heart Rate peak (bpm) 119.4 ± 8.9 131.5 ± 17.2 110.7 ± 15.2 117 ± 10.8
Systolic Blood Pressure peak (mm Hg) 151.6 ± 22.9 152.7 ± 12.5 164.4 ± 22.9 160 ± 24.5
Diastolic Blood Pressure peak (mm Hg) 88.8 ± 16.9 88.3 ± 14.5 86.6 ± 7.0 89.4 ± 8.8
Dyspnea peak (Borg) 4.0 ± 2.1 2.5 ± 1.5 4.0 ± 1.5 3.3 ± 2.0
Lactate peak (mMol/L) 2.0 ± 1.0 2.9 ± 1.0 1.7 ± 0.7 1.8 ± 0.8
Oxygen Consumption peak (L/min) 0.8 ± 0.1 1.1 ± 0.5 0.9 ± 0.3 1.3 ± 0.3*
Carbonic Gas Production peak (L/min) 0.7 ± 0.1 1.0 ± 0.5 0.9 ± 0.2 1.1 ± 0.3
*Significantly different from pretraining. P d” 0.05.
significantly reduced only for the PT+B group. In the
posttreatment evaluation, lower values of blood lactate were
obtained in the PT+B group when compared PT alone (2.5
± 0.9 versus 1.3 ± 0.7 mMol/L). Neither of the groups stud-
ied presented any significant alterations for DBP.
Regarding values for peak physical exercise, the intra- and
intergroup analysis did not reveal significant alterations in vari-
ables for HR, SBP, DBP, SpO2, sensation of dyspnea, blood
lactates, or VCO2 (Table 3). However, intragroup analysis re-
vealed a significant increase in VO2 only in the PT+B group
(0.9 ± 0.3 to 1.3 ± 0.3 L/min). A significant increase in respi-
ratory muscle strength was found for both groups (Figure 1).
Regarding the walking distance in CPT, a statistically
significant increase occurred in both groups (Figure 2).
PImax PT: maximum inspiratory pressure in group performing physical training alone.
PEmax PT: maximum expiratory pressure in group performing physical training alone.
PImax PT+B: maximum inspiratory pressure in group undergoing physical training associated with the use of
noninvasive ventilation.
PEmax PT+B: maximum expiratory pressure in group undergoing physical training associated with the use of
noninvasive ventilation.
Figure 1 - Effect of physical training associated or not with the use of noninvasive ventilation on maximum expiratory and inspiratory pressure
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DISCUSSION
Our main findings in this study regarding intragroup
analysis at identical levels of physical exercise in CPT
were: 1) a significant increase of SPO2 and a decrease of
the sensation of dyspnea in both groups; 2) significant re-
ductions of HR, SBP, and blood lactate only in the PT+B
group; and 3) a significant reduction of blood lactate in the
PT+B group when compared to PT alone. Regarding the
peak values in CPT, the intragroup analysis showed a sig-
nificant increase in oxygen consumption only for the PT+B
group.
In our study, both the group undergoing PT alone and
the group undergoing PT+ BiPAP® presented significant
improvements in SpO2, sensation of dyspnea, respiratory
muscle strength, and the distance walked in CPT. The re-
sults of the present study are in accordance with those ob-
tained by other authors,11,25,26 who observed an increase in
respiratory muscle strength, improvement in physical ca-
pacity, and a reduction in dyspnea in patients with COPD
undergoing PT.
Physical exercise has been described as having an es-
sential role in the rehabilitation of patients with COPD.
Dyspnea leads to progressive physical deconditioning, caus-
ing losses in strength and peripheral muscle endurance, in
addition to metabolic and gas exchange abnormalities.1
Regarding the period of physical training, reported studies
show that PT programs produce physiological effects in
these patients after a minimum of 6 to 8 weeks. Some12
show that this 6 to 8 week period may be relatively short
for producing physiological adaptations. For this reason,
we opted for a training period of 12 weeks, with the ob-
jective of evaluating whether the training period could also
be an additional factor influencing the results obtained be-
tween groups.
Our results agree with a number of reports showing that
NIV can produce additional effects during exercise in pa-
tients with COPD. Keilty27 observed a significant improve-
ment in dyspnea symptoms during a submaximal test with
the application of pressure support in patients with COPD.
Other studies, which have investigated the role of NIV as-
sociated with physical training, have also shown beneficial
effects, such as better exercise tolerance,18,28,29 a reduction
in dyspnea,18 an increase in arterial oxygenation,28 and an
increase in respiratory muscle strength.17,30,31
In this study, we found that only the group that under-
went PT with BiPAP® ventilation support had a significant
reduction in SBP, HR, and blood lactate at the same inten-
sity of exercise. The attenuation of these cardiovascular re-
sponses can be explained by the increase in muscular oxi-
dation capacity, slowing the cardiovascular adjustments
through metaboreflex response. Costes et al,18 in associat-
ing PT with NIV, observed a significant increase in oxy-
gen consumption, but they found that there was no signifi-
cant difference in blood lactate among the patients
studied.
The use of NIV associated with physical exercise has
been a useful option in patients with COPD and greater
ventilatory limitation during physical exercise because it
is a method that can offer respiratory assistance. In our pa-
tients with COPD, the use of BiPAP® associated with PT
on a treadmill significantly reduced the blood lactate, at
Pre PT: preintervention distance traveled for group undergoing physical training alone.
Post PT: postintervention distance traveled for group undergoing physical training alone.
Pre PTB: preintervention distance traveled for group undergoing physical training associated with the use of non
invasive ventilation.
Post PTB: postintervention distance traveled for group undergoing physical training associated with the use of non
invasive ventilation.
Figure 2 - Effect of physical training associated or not with the use of noninvasive ventilation on walking distance, by individual participant
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ables and in a lower production of blood lactate when this
intervention is associated with PT on a treadmill. These re-
sults were concomitantly obtained with the increase of oxy-
gen consumption at peak exercise.
A first limitation of this study is the small number of
patients studied, given the strict criteria for inclusion in this
study. Another limitation was the impossibility of obtain-
ing breath-to-breath ventilatory and metabolic data because
the equipment evaluated these variables in averages of 20
seconds. In addition, it was not possible to evaluate the flow
limitation and dynamic hyperinflation during exercise,
which would have supplied an important evaluation of the
noninvasive ventilation during the physical exercise. De-
spite these limitations, differences between the interven-
tions studied can be observed with the methodology ap-
plied in this study.
Finally, we conclude that physical training associated
with the application of 2 levels of pressure in the airways
provided an improved aerobic capacity in our patients, and
this adjunct therapy can be a useful recourse during physi-
cal rehabilitation of patients with COPD who present a mod-
erate-to-severe COPD and dyspnea in response to effort.
the same exercise intensity as the CPT exercise. Regard-
ing blood lactate, our results are in agreement with the stud-
ies by Borghi-Silva13 and Pires Di Lorenzo et al,32 who,
studied patients with a greater degree of obstruction and
observed a significant reduction of blood lactate only in
the group that performed physical training associated with
bi-level NIV. These results can be explained by the im-
provement in the oxidative muscle capacity due to the
greater availability of oxygen to the tissue; even though we
did not observe differences between groups for SpO2, the
PT+B group presented lower pretreatment base values; that
is, they were more hypoxemic.
The benefits of the use of BiPAP® associated with physi-
cal exercise can probably be accounted for by the reduc-
tion of work for the diaphragm muscle, given the dynamic
coupling of neuroventilation and the reduction of
hyperinsuflation during physical effort. Aside from this, in
diversion of blood flow from the peripheral muscle to the
ventilatory muscle limits the continuity of physical exer-
cise.33 It is possible that NIV can diminish mid-intratho-
racic pressure and improve cardiac output, which could re-
sult in attenuation of the response of cardiovascular vari-
RESUMO
A. Toledo, A. Borghi-Silva, L.M.M. Sampaio, Ribeiro K.P,
V. Baldissera, D. Costa. O impacto da ventilação não-
invasiva no treinamento físico em pacientes com doença
pulmonar obstrutiva crônica moderada a grave. Clinics.
2007;62(2):113-20.
OBJETIVO: Avaliar a influência do treinamento físico,
com e sem ventilação não invasiva com dois níveis de
pressão nas vias aéreas (BiPAP®), em pacientes com doença
pulmonar obstrutiva crônica.
MÉTODOS: Dezoito pacientes com VEF1=34±8% do
previsto, idade média de 68±9 anos, foram randomicamente
distribuídos em dois grupos, um grupo realizando
treinamento físico em esteira e outro grupo realizando
treinamento físico associado ao BiPAP® (treinamento
físico+B), durante 30 minutos, 3 vezes por semana, por 12
semanas. A velocidade do treinamento foi baseada no teste
cardiopulmonar realizado pré e pós-intervenção, com
registro dos valores de freqüência cardíaca, pressão arte-
rial sistólica, pressão arterial diastólica, saturação periférica
de oxigênio, lactato sanguíneo, sensação de dispnéia, força
muscular respiratória e análise de gases expirados como
consumo de oxigênio, produção de dióxido de carbono.
RESULTADOS: Em ambos os grupos houve melhora
significativa na dispnéia e saturação periférica de oxigênio no
mesmo nível de esforço, na distância percorrida no teste
119
CLINICS 2007;62(2):113-20 The impact of noninvasive ventilation during the physical training
Toledo A et al.
cardiopulmonar e na força muscular respiratória (p<0,05).
Somente o grupo treinamento físico+B teve melhora
significativa de freqüência cardíaca, pressão arterial sistólica
e consumo de oxigênio após treinamento (p<0,05). Além
disso, significativa redução do lactato sanguíneo foi observada
para o mesmo nível de exercício no grupo treinamento
físico+B quando comparado com treinamento físico isolado
(1,3±0,7 e 2,5±0,9mMol/L, p<0,05, respectivamente).
CONCLUSÃO: O treinamento físico associado com
BiPAP® aumenta a capacidade muscular oxidativa, e pode
ser um recurso coadjuvante da reabilitação física de
pacientes com doença pulmonar obstrutiva crônica.
UNITERMOS: Doença pulmonar obstrutiva crônica
(DPOC). Treinamento físico. BiPAP®. Ventilação não
invasiva. Teste cardiopulmonar.
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